Published: 2021-10-26

Mucormycosis during the second wave of COVID-19 in India

Mudit Mittal, Rakesh Srivastava


Background: The so called “black fungus epidemic” struck India during the second wave of COVID-19 pandemic. Large numbers of patients were being reported, posing a challenging situation for clinicians. The treatment options were limited, and rescue surgery was mutilating, anti-fungal medicines became short of supply soon, prognosis remained poor. Objective was to understand a unifying pathophysiological picture with a framework to check this post Covid epidemic, especially in context with South-east-Asia. 

Methods: The clinical, radiological, surgical data of patients presented with symptoms of rhino-orbito-cerebral complications, collected and analyzed.

Results: 80.9% of operated patient had thrombosis of identifiable major vessels. The 76.7% patient had cerebral venous thrombosis. The 30% patient had internal carotid artery narrowing on imaging. Fungal staining was positive in 72% patient. We found level of D dimer was high in 81.3% patients and 83.9% patients had blood sugar level raised at the time of presentation.

Conclusions: Hyper thrombotic state of COVID-19 in diabetes and injudicious use of steroids predisposed susceptible patients to thromboembolic phenomena, leading to necrosis of tissue and secondary fungal infection.


COVID-19, Hypercoagulability, Mucormycosis, Orbital cellulitis, Cavernous sinus thrombosis

Full Text:



Prakash H, Chakrabarti A. Epidemiology of Mucormycosis in India. Microorganisms. 2021;9(3):523.

Ahmed O, Aladham Y, Mahmood S, Abdelnaby MM. Complicated sinusitis with sphenopalatine artery thrombosis in a COVID-19 patient: a case report. J Surg Case Rep. 2021;2021(3):rjab010.

Abou-Ismail MY, Diamond A, Kapoor S, Arafah Y, Nayak L. The hypercoagulable state in COVID-19: Incidence, pathophysiology, and management. Thromb Res. 2020;194:101-15.

Thompson A, Morgan C, Smith P, Jones C, Ball H, Coulthard EJ et al. Cerebral venous sinus thrombosis associated with COVID-19. Pract Neurol. 2020;practneurol-2020-002678.

Ebright JR, Pace MT, Niazi AF. Septic Thrombosis of the Cavernous Sinuses. Arch Intern Med. 2001;161(22):2671-6.

Jones TH, Bergvall V, Bradshaw JP. Carotid artery stenoses and thrombosis secondary to cavernous sinus thromboses in Fusobacterium necrophorum meningitis. Postgrad Med J. 1990;66(779):747-50.

Benndorf G. Anatomy of the cavernous sinus and related structures. In: Benndorf G, editor. Dural Cavernous Sinus Fistulas. Diagnosis and Endovascular Therapy. Berlin and Heidelberg: Springer. 2010;16-46.

Bhandari J, Thada PK, Nagalli S. Rhinocerebral Mucormycosis. In: StatPearls. Treasure Island (FL): Stat Pearls. 2021. Available at: Accessed on 10 Feb 2020.

Sharma S, Grover M, Bhargava S, Samdani S, Kataria T. Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum. J Laryngol Otol. 2021;1-6.

Patel SD, Kollar R, Troy P, Song X, Khaled M, Parra A et al. Malignant Cerebral Ischemia in A COVID-19 Infected Patient: Case Review and Histopathological Findings. J Stroke Cerebrovasc Dis. 2020;29(11):105231.

Kolekar JS. Rhinocerebral mucormycosis: a retrospective study. Indian J Otolaryngol Head Neck Surg. 2015;67(1):93-6.

Fernandez-Nieto D, Jimenez-Cauhe J, Suarez-Valle A, Moreno-Arrones OM, Saceda-Corralo D, Arana-Raja A et al. Characterization of acute acral skin lesions in nonhospitalized patients: A case series of 132 patients during the COVID-19 outbreak. J Am Acad Dermatol. 2020;83(1):e61-3.

Turbin RE, Wawrzusin PJ, Sakla NM, Traba CM, Wong KG, Mirani N et al. Orbital cellulitis, sinusitis and intracranial abnormalities in two adolescents with COVID-19. Orbit. 2020;39:305-10.

Emes Y, Yalcin S, Aybar B, Bilici IS. Infratemporal fossa infection with inferior alveolar nerve involvement. J Istanb Univ Fac Dent. 2016;50(3):46-50.

Van der Poel NA, Mourits MP, De Win MML, Coutinho JM, Dikkers FG. Prognosis of septic cavernous sinus thrombosis remarkably improved: a case series of 12 patients and literature review. Eur Arch Otorhinolaryngol. 2018;275(9):2387-95.

Anjana RM, Deepa M, Pradeepa R, Mahanta J, Narain K, Das HK et al. ICMR–INDIAB Collaborative Study Group. Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study. Lancet Diabetes Endocrinol. 2017;5(8):585-96.

Pal R, Bhadada SK. COVID-19 and diabetes mellitus: An unholy interaction of two pandemics. Diabetes Metab Syndr. 2020;14(4):513-7.

Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost. 2020;18(4):844-7.

Buttolph A, Sapra A. Gangrene. In: StatPearls. Treasure Island (FL): StatPearls. 2021;32809387.